Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01810276 · ClinicalTrials.gov registry record · NA
Safety of Platelet Transfusion in Patients on Antiplatelet Therapy With Traumatic Head Injury
A NA study, sponsored by Christiana Care Health Services.
- Terminated
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT01810276 is a NA study that was terminated before completion, run by Christiana Care Health Services. The registered enrollment target is 40 participants.
The verdict
NCT01810276, a NA study, was terminated before completion, sponsored by Christiana Care Health Services.
- TERMINATED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
The objective of this study is to determine if the administration of platelets will improve outcome in patients with ICH who are being treated with either aspirin, a thienopyridine (ticlodipine, clopidogrel, prasugrel) or a combination of both. The study has four specific aims: 1. To determine what affect platelet administration will have on bleeding in the brain. 2. To determine what affect platelet administration will have on brain function. Several assessments to test the functioning of the brain will be performed at enrollment and throughout the study. Comparing the results of these assessments between the experimental and control groups should allow us to determine if platelet administration improves outcomes in patients with bleeding in the brain exposed to antiplatelet therapy. 3. An important risk of reversing antiplatelet therapy is exposing the patient to the very complications this therapy was designed to prevent. Therefore, tracking complications will be a very important part of this study. The investigators will compare the rates of death, heart attack, stroke and clots in the veins between groups. 4. Some patients (10-40%) have limited responsiveness to antiplatelet therapy. While platelet responsiveness, as measured by a special platelet blood test, will not affect enrollment, the investigators feel it will be important to measure.
Interventions
- OTHER Saline
- OTHER Platelets
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2012-06 |
| Est. Completion | 2013-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01810276
The ClinicalTrials.gov registry entry for NCT01810276 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Christiana Care Health Services, which has 82 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Saline is the first listed.
NCT01810276 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01810276 about?
NCT01810276 is a clinical study titled "Safety of Platelet Transfusion in Patients on Antiplatelet Therapy With Traumatic Head Injury". The objective of this study is to determine if the administration of platelets will improve outcome in patients with ICH who are being treated with either aspirin, a thienopyridine (ticlodipine, clopidogrel, prasugrel) or a combination of both. The study has four specific aims: 1. To determine what...
What is the current status of trial NCT01810276?
This trial is currently terminated. It is a NA study. The enrollment target is 40 participants. The study started on 2012-06. Estimated completion is 2013-04.
What interventions are being tested in trial NCT01810276?
The interventions under investigation include: Saline (OTHER), Platelets (OTHER).
Who is sponsoring clinical trial NCT01810276?
This trial is sponsored by Christiana Care Health Services, which has 82 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.